Is it possible to find pharmaceutical grade mdma (like MAPS) on dn?

Ok i'm looking for therapeutical mdma (99% pure) for ptsd but i'm from europe. Normal junk mdma is not enough, its therapeutic effects are limited. (1x every 3+months) So i need the purest stuff but i have not found anything coming close to pharmaceutical grade.

Is it possible to find such a product on dark markets? How much could it be for a gram realistically?

Ty guys!


Comments


[32 Points] GurningDownTheHouse:

Dude, that’s not how it works at all. You can’t just take MDMA to cure/treat your PTSD. You need a therapist to work with through the process. And “pharmaceutical grade MDMA” means nothing.


[16 Points] diOpAnonMu:

The three month rule was not because people are getting 90% pure instead of 99% pure.

Pharmaceutical grade is never going to happen, it has requirements beyond the purity level, and no illicit manufacturer is going to have their lab audited for this purpose.


[8 Points] shesdeadsusan:

You don't just take mdma and cure yourself of PTSD, you work with a behaviour therapist. Also, the DNM have excellent MDMA coming out of europe tbh.


[6 Points] GirlsDontLikeIce:

Yeah. duh that's what we all buy.


[2 Points] mymuse100:

Simple answer NO, you will not get MAPS quality on the Darknet. https://motherboard.vice.com/en_us/article/4xay43/how-to-legally-buy-a-kilo-of-pure-mdma

Getting your hands on illicit drugs illegally is easy—as simple as firing off a text. But legally acquiring a massive quantity of certified GMP, 99 percent pure, high yield MDMA? That requires a long journey through a labyrinth of regulation, oversight, and bureaucracy.

It all starts with asking the government if you can please buy some psychedelics.


How to Legally Buy a Kilo of Pure MDMA (MAPS) Unfortunately, MAPS can't do much with this stash of Molly. In order for MAPS to move into phase three of its therapy trials in 2017, the Food and Drug Administration requires it to use MDMA that is certified under Good Manufacturing Practices (GMP), which this original batch is not. That means it has to source a brand new kilo of pure MDMA.

How to get 99.95% MDMA


1) Step one: be a medical researcher.

Step 2: Getting Permission

step 3: : A Recipe for Molly

Somewhere in the English countryside, off the coast of the North Sea, there's a pharmaceutical company contracted to make MAPS's MDMA. An expert at the company was more than happy to talk to me, but we had to keep some details secret, including the company's name and location, and name of the person I interviewed. When you're about to make 1,000 grams of an exceptionally high quality, 99 percent pure version of a popular party drug, you want to take some precautions.

"It might attract some unwanted attention," my source told me.

The pharmaceutical manufacturer—let's call them Company X, for the hell of it—won't be producing MDMA tablets. This isn't like a hit of Molly you buy off a girl wearing white fuzzy boots at an outdoor concert in the middle of summer. Company X will be making the active pharmaceutical ingredient, or API: the 99 percent pure, powdered form of the drug. Just like a Tylenol pill isn't pure acetaminophen, a Molly tablet isn't pure MDMA. There are fillers and binders (and in the case of street Molly, a whole host of other possible ingredients) to turn the pure API powder into something that's easy to pop.

If you were trying to make MDMA for the first time, even following the "recipe" exactly, the yield and quality would be much lower than what MAPS needs: one kilogram of MDMA that is as pure as possible, ideally 99.5 percent or higher. This is because there are details that can't be captured in the reaction schemes, so it takes time to refine the process, my source explained. Luckily, other companies with experience making MDMA have already refined the process and are willing to share their knowledge for a price, so MAPS purchased this "annotated recipe," giving the Company X a head start on concocting the perfect, GMP MDMA recipe.

Certified GMP basically means you can prove that every step in making the drug, from the facility producing the source chemicals to the final packaging process, follows strict procedures that are known to result in a safe and consistent drug. This requires careful documentation and oversight from the drug manufacturer. An inspector could come to the manufacturer and demand to see something as specific as the procedure for ensuring a beaker is clean before a chemical is poured into it, according to Company X. It's a very precise endeavor. But that precision means that not only will MAPS's new kilo of MDMA be pure and safe, but that every batch after that will be identical to it.

There are lots of security steps on this end of the process as well: Company X has a license to handle Schedule I drugs already, but also needed to meet certain requirements to hold the raw ingredients to make MDMA. Company X needed to prove its facility was equipped with security systems and provide the UK government with a thorough outline of what the company is making, where that products are going, and what the product will be used for. And since the MDMA is going across the US border, the company needed special permission from the FDA and DEA to ship it stateside, too.

Company X is currently in the process of nailing down the MDMA GMP production by experimenting with small batches. Once the product meets all the standards, it will produce the kilo and send it to MAPS some time in the next year.

But even with the MDMA in MAPS's possession, getting it into patients' hands—and heads—requires leaping through a few more hoops.

Step Three: Dosing

Even with its layers of security and vault-like safe stuffed with ecstasy, the MAPS clinic where its MDMA trials take place is quite unassuming.

It's no cold, sterile laboratory: the consultation rooms more closely resemble an upscale retirement home, with plush chairs, neutral carpeting, and cheery paintings. During a session, a PTSD patient takes a dose of Molly (without knowing how much), sits back, and waits for the roll. It's a deeply personalized process, the trip enabling the patient to reel back to traumatic moments in their memory with the psychedelic effects as a gentle buffer. A session, which lasts several hours and requires an overnight stay at the clinic, flows between guided therapy and quiet reflection. It's all part of a process intended to heal deep psychic wounds, with the help of the MDMA.

The bulk of the MDMA API (remember, this is a pure powdered form of the drug) can't all physically be stored in Mithoefer's office. (It's a lot of Molly.) Right now, MAPS stores its MDMA with a company called Organix—that's the nondescript Massachusetts building—which has a license to store and ship the pure, powdered drug. But to dole it out to patients, it's better to have a pill.Powders are unwieldy and difficult to distribute to patients with precision, which is needed for a study. The dose of MDMA given to PTSD patients in MAPS's study—previous phases in the study doled out 30, 75, and 125 milligram doses to different patients—needs to be compressed and encapsulated into an easy-to-pop pill.

Emerson told me MAPS is looking for a company that can pre-package the MDMA doses for the study, but in the meantime researchers have found a workaround. When it's time to conduct a trial, MAPS orders a small amount of the raw powder from the holding facility at Organix, which, in spite of all the intensive security requirements, ultimately ships the MDMA in a plain, old cardboard Fedex box directly to Mithoefer's office. There, it has to be received by Mithoefer himself and immediately tucked away in that 2,000-lb safe.

This is where it gets really tricky. While Mithoefer has a license to dole out the MDMA, he can't package it himself, so a pharmacist has to come to the office to make the pills. Since MAPS is doing a double-blind trial, Mithoefer also can't know which dose each patient is getting. But his license dictates that he can't leave the room when the MDMA isn't locked up. So MAPS needed to find a way to have a pharmacist turn the powder into pills with Mithoefer in the room but without him knowing how much powder was going into each pill.

The solution to this conundrum is actually pretty simple: the pharmacist follows specific directions from MAPS to create the doses with Mithoefer in the room, but hidden from view by a cardboard partition, Emerson said. Since the trials have been small so far, this process has worked well, but Emerson said if MAPS wants to do more expansive trials, it'll need a facility that can pre-package all the doses ahead of time.

With the doses packaged and labelled by the pharmacist, Mithoefer is finally able to administer a dose to a patient and begin the therapy.


[1 Points] meowmix686:

Ordering fromThe Netherlands is your best bet IMO


[1 Points] FishyStuffTA1:

I’d say look at NL vendors and sort by price High to Low and have a look at reviews and talk to vendors before purchasing asking for test results to prove its purity , If they are genuinely selling what they advertise they will have no problem providing info especially if you’re paying the premium for the purity


[1 Points] pacific-hero:

Can't recommend a vendor due to rule 4 but if you were to check my post history it would possibly guide you in the right direction


[1 Points] drimilr:

How do you know you haven't found pharma grade MDMA?


[1 Points] 100blooot:

find you some source A. When i got some last time it was tested very high


[1 Points] jaboingboing69:

You probably take it too often and too much.

When people say the drug isn't working chances are it's not the drug but their tolerance.


[-1 Points] Bilbobadger:

Best your ever going to get is 84% on the markets and you realise the 3 month rule is flexible